Íàöèîíàëüíûé
èíñòèòóò ôòèçèàòðèè è ïóëüìîíîëîãèè
èìåíè Ô.Ã. ßíîâñêîãî

Ïåðåõîä íà òèòóëüíóþ ñòðàíèöóÏîèñê ïî ñàéòó

Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë

Îá èíñòèòóòå:

èñòîðèÿ,

îáùèå ïîëîæåíèÿ,

ñòðóêòóðà,

íàó÷íàÿ äåÿòåëüíîñòü,

ïëàíû ÍÈÐ,

ëå÷åáíî-äèàãíîñòè÷åñêàÿ ðàáîòà,

âåäóùèå ó÷åíûå

Íîâîñòè:

íîâèíêè íà ñàéòå

Íàøè èçäàíèÿ:

"Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë" (ÓÏÆ),
"Óêðàèíñêèé õèìèîòåðàïåâòè÷åñêèé æóðíàë" (ÓÕÆ),
"Àñòìà è àëëåðãèÿ"

Îðèãèíàëüíûå ñòàòüè:

îðèãèíàëüíûå íàó÷íûå ñòàòüè, ðàíåå íèãäå íå ïóáëèêîâàâøèåñÿ

Íîâîââåäåíèÿ:

ìåòîäè÷åñêèå ðåêîìåíäàöèè, èíôîðìàöèîííûå ïèñüìà,
âåäîìñòâåííûå èíñòðóêöèè,
íîâîââåäåíèÿ, ìîíîãðàôèè

Ïàòåíòû:

ïàòåíòû è àâòîðñêèå ñâèäåòåëüñòâà èíñòèòóòà

Îò÷åòû î ÍÈÐ:

ðåôåðàòû çàêîí÷åííûõ íàó÷íî-èññëåäîâàòåëüñêèõ ðàáîò

Ïîäãîòîâêà êàäðîâ:

àñïèðàíòóðà,

êëèíè÷åñêàÿ îðäèíàòóðà,
êóðñû èíôîðìàöèè è ñòàæèðîâêè,

â ïîìîùü àñïèðàíòó è ñîèñêàòåëþ

Íàó÷íûå ôîðóìû:

ðåçîëþöèè è îáðàùåíèÿ ñúåçäîâ, êîíôåðåíöèé, ñîâåùàíèé...

Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ:

îáçîðû ëèòåðàòóðû, ñòàòèñòè÷åñêàÿ èíôîðìàöèÿ, íîâîå â ëå÷åíèè òóáåðêóëåçà è íåñïåöèôè÷åñêèõ çàáîëåâàíèé ëåãêèõ...

Èíôîðìàöèÿ äëÿ íàñåëåíèÿ:

ïîëåçíàÿ èíôîðìàöèÿ î çàáîëåâàíèÿõ ëåãêèõ, èõ ïðîôèëàêòèêå è ëå÷åíèè

2006. - ¹ 1.
ÑÎÄÅÐÆÀÍÈÅ / CONTENTS

ÏÅÐÅÄÎÂÀ ÑÒÀÒÒß / EDITORIAL

 

Þ. ². Ôåùåíêî, Î. ß. Äçþáëèê
ÀÍÒÈÁ²ÎÒÈÊÎÒÅÐÀÏ²ß ÕÂÎÐÈÕ ÍÀ ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎÍ²Þ Â ÀÌÁÓËÀÒÎÐÍÈÕ ÓÌÎÂÀÕ

®

Yu. I. Feshchenko, O. Ya. Dzyublik
ANTIBACTERIAL THERAPY OF OUT-PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

 

 

ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ÎRIGINALS


Ò. Î. Ïåðöåâà, ß. Â. Ïîïîâè÷
ÀÍÀË²Ç Ê˲Ͳ×ÍÎÃÎ ÏÅÐÅÁ²ÃÓ ÍÅÃÎÑϲÒÀËÜÍί ÏÍÅÂÌÎͲ¯ Ó ÕÂÎÐÈÕ ÍÀ ÑÒÀÖ²ÎÍÀÐÍÎÌÓ ÅÒÀϲ ÒÀ ÄÎÑÂ²Ä ÇÀÑÒÎÑÓÂÀÍÍß ÇÀÕÈÙÅÍÎÃÎ ÏÅͲֲ˲ÍÓ Â ÐÅÆÈ̲ ÑÒÓÏÅÍÅÂί ÒÅÐÀϲ¯

®

T. O. Pertseva, Ya. V. Popovich
ANALYSIS OF CLINICAL COURSE OF COMMUNITY-ACQUIRED PNEUMONIA IN HOSPITALIZED PATIENTS AND THE EXPERIENCE OF ADMINISTRATION OF PROTECTED PENICILLIN AS A SEQUENTIAL THERAPY

 

Í. Ì. Øóáà, Ò. Ä. Âîðîíîâà
ÍÈÇÜÊÎÌÎËÅÊÓËßÐͲ ԲDzÎËÎò×ÍÎ ÀÊÒÈÂͲ ÐÅ×ÎÂÈÍÈ ßÊ ÏÎÊÀÇÍÈÊ ÍÀßÂÍÎÑÒ² ÔÀÊÒÎв ÐÈÇÈÊÓ ÒÀ ÅÔÅÊÒÈÂÍÎÑÒ² ˲ÊÓÂÀÍÍß Ó ÕÂÎÐÈÕ ÍÀ ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎͲÞ

®

N. M. Shuba, T. D. Voronova
LOW-MOLECULAR PHYSIOLOGICALLY ACTIVE SUBSTANCES AS AN INDICATOR OF RISK FACTORS AND TREATMENT EFFICIENCY IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

 

Â. Â. Ìàêñèì³â
ÑÏÎÍÒÀÍÍÀ ÏÐÎÄÓÊÖ²ß ÖÈÒÎʲͲ ÒÀ ËÅÉÊÎÒвªÍÓ Â4 ÌÎÍÎÖÈÒÀÌÈ/ ÌÀÊÐÎÔÀÃÀÌÈ ÏÅÐÈÔÅвÉÍί ÊÐβ Ó ÕÂÎÐÈÕ ÍÀ ÍÅÃÎÑϲÒÀËÜÍÓ ÏÍÅÂÌÎͲÞ

®

V. V. Maksymiv
SPONTANEOUS PRODUCTION OF CYTOKINES AND LEUKOTRIENE B4 BY PERIPHERAL BLOOD MONOCYTES/MACROPHAGES IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

 

Ñ. Ì. Ïîëèâîäà, Î. Â. Êóëèíè÷
ÎÖ²ÍÊÀ ÅÔÅÊÒÈÂÍÎÑÒ² ÒÀ ÏÅÐÅÍÎÑÈÌÎÑÒ² ÔÒÎÐÕ²ÍÎËÎÍÀ ²²² ÏÎÊÎ˲ÍÍß "ÔËÎÊѲÓÌ"  ÏÎвÂÍßÍͲ Ç ÎÐÈòÍÀËÜÍÈÌ ÏÐÅÏÀÐÀÒÎÌ Â Ë²ÊÓÂÀÍͲ ÇÀÃÎÑÒÐÅÍÍß ÕÎÇË

®

S. M. Polyvoda, O. V. Kulinich
EFFICACY AND TOLERABILITY OF 3RD GENERATION FLUOROQUINOLONE FLOXIUM IN COMPARISON WITH ORIGINAL DRUG IN TREATMENT OF COPD EXACERBATION

 

Â. Â. Åôèìîâ, Ë. Ñ. Âîåéêîâà, Â. È. Áëàæêî, Ë. Ì. Ñàìîõèíà, È. Â. Òàëàëàé ÏÐÈÌÅÍÅÍÈÅ ÝÏÀÄÎËÀ Ó ÁÎËÜÍÛÕ ÕÐÎÍÈ×ÅÑÊÈÌ ÎÁÑÒÐÓÊÒÈÂÍÛÌ ÇÀÁÎËÅÂÀÍÈÅÌ ËÅÃÊÈÕ

®

V. V. Yefimov, L. S. Voyeykova, V. I. Blazhko, L. M. Samokhina, I. V. Talalay
APPLICATION OF EPADOL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY
DISEASE

 

². Ï. Êàéäàøåâ, Ä. Ì. Áîéêî, Â. Â. Ãîðáàòåíêî
ÂÈÊÎÐÈÑÒÀÍÍß ÀÍÒÈÃÎÌÎÒÎÊÑÈ×ÍÈÕ ÏÐÅÏÀÐÀÒ²Â Ó ÊÎÌÏËÅÊÑÍ²É ÒÅÐÀϲ¯ ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ ²-²² ÑÒÀIJ¯

®

I. P. Kaidashev, D. M. Boyko, V. V. Gorbatenko
THE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF ²-²² STAGE USING ANTIHOMOTOXIC PREPARATIONS

 

Þ. Ì. Êàë³í³÷åíêî, Ì. Ì. Îñòðîâñüêèé
ÎÖ²ÍÊÀ ²ÍÒÅÐËÅÉʲÍÎÂÎÃÎ ÏÐÎÔ²ËÞ ÏÐÈ ÕÐÎͲ×ÍÎÌÓ ÎÁÑÒÐÓÊÒÈÂÍÎÌÓ ÇÀÕÂÎÐÞÂÀÍͲ ËÅÃÅÍÜ

®

Yu. N. Kalinichenko, M. M. Ostrovskiy
ESTIMATION OF INTERLEUKIN PROFILE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 

 

Â. Ê. Ãàâðèñþê, Í. È. Ãóìåíþê, Í. Ä. Ìîðñêàÿ, Ò. Â. ßõíèöà, Å. À. Ìåðåíêîâà
ÑÐÀÂÍÈÒÅËÜÍÎÅ ÈÇÓ×ÅÍÈÅ ÂËÈßÍÈß ÐÅÎÑÎÐÁÈËÀÊÒÀ È ÐÅÎÏÎËÈÃËÞÊÈÍÀ ÍÀ ÑÎÑÒÎßÍÈÅ ÃÅÌÎÊÎÍÖÅÍÒÐÀÖÈÈ, ÂßÇÊÎÑÒÈ ÊÐÎÂÈ È ÀÃÐÅÃÀÖÈÎÍÍÎÉ ÑÏÎÑÎÁÍÎÑÒÈ ÒÐÎÌÁÎÖÈÒÎÂ Ó ÁÎËÜÍÛÕ Ñ ÕÐÎÍÈ×ÅÑÊÈÌ ËÅÃÎ×ÍÛÌ ÑÅÐÄÖÅÌ È ÕÐÎÍÈ×ÅÑÊÎÉ ÑÅÐÄÅ×ÍÎÉ ÍÅÄÎÑÒÀÒÎ×ÍÎÑÒÜÞ

®

V. K. Gavrysyuk, N. I. Gumenyuk, N. D. Morskaya, T. V. Yahnitsa, E. A. Merenkova
COMPARATIVE STUDY OF RHEOSORBILACT AND RHEOPOLYGLUKIN INFLUENCE ON BLOOD CONCENTRATION, VISCOSITY AND PLATELETS AGGREGATION IN PATIENTS WITH COR PULONALE AND CHRONIC HEART FAILURE



Å. À. Ìåðåíêîâà, Í. Å. Ìîíîãàðîâà
ÑÎÑÒÎßÍÈÅ ÀÃÐÅÃÀÖÈÎÍÍÎÉ ÑÏÎÑÎÁÍÎÑÒÈ ÒÐÎÌÁÎÖÈÒΠÏÐÈ ÏÀÒÎËÎÃÈÈ ËÅÃÊÈÕ Ó ÁÎËÜÍÛÕ ÐÀÇËÈ×ÍÛÕ ÍÎÇÎËÎÃÈ×ÅÑÊÈÕ ÃÐÓÏÏ

®

Ye. A. Merenkova, N. Ye. Monogarova
PLATELETS AGGREGATION IN PATIENTS WITH VARIOUS PULMONARY DISEASES

 

Ã. Ï. Ïîáåäüîííà
ÌÅÄÈÊÎ-ÅÊÎÍÎ̲×Ͳ ÀÑÏÅÊÒÈ Ë²ÊÓÂÀÍÍß ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ

®

G. P. Pobedyonnaja
MEDICAL AND ECONOMICAL ASPECTS OF EFFECTIVENESS OF ASTHMA THERAPY

 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

Â. Ï. Êîñòðîìèíà, Ë. Á. ßðîùóê
ÔÐÎÌÈËÈÄ ÓÍÎ - ÍÎÂÀß ÔÎÐÌÀ È ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ Â ËÅ×ÅÍÈÈ ÇÀÁÎËÅÂÀÍÈÉ ÎÐÃÀÍΠÄÛÕÀÍÈß Ó ÄÅÒÅÉ

®

V. P. Kostromina, L. B. Yaroshchuk
FROMILID-UNO - NOVEL FORMULATION AND NEW OPPORTUNITIES IN TREATMENT OF RESPIRATORY DISEASES IN CHILDREN

 


ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÔÒÈDzÀÒв¯ /TOPICAL ISSUES OF PHTHISIATRY
 

Â. Ì. Ìåëüíèê, ². Î. Íîâîæèëîâà, À. Ì. Ïðèõîäüêî, Î. Ð. Ñìåòàí³íà
ÄÈÍÀ̲ÊÀ ÇÀÕÂÎÐÞÂÀÍÎÑÒ² ÒÀ ÑÌÅÐÒÍÎÑÒ² Â²Ä ÒÓÁÅÐÊÓËÜÎÇÓ ÄÎ ² Ï²Ä ×ÀÑ ÅϲÄÅ̲¯: ÒÅÍÄÅÍÖ²¯ ÒÀ ÐÅòÎÍÀËÜͲ ÎÑÎÁËÈÂÎÑÒ²

®

V. M. Melnyk, I. A. Novozhilova, A. N. Prychodko, O. R. Smetanina
DYNAMICS OF TUBERCULOSIS MORBIDITY AND MORTALITY BEFORE AND DURING THE EPIDEMIC, REGIONAL PECULIARITIES

 

É. Á. Áÿëèê, Ë. Ì. Öèãàíêîâà, Â. Â. Äàâèäåíêî, ². Â. Ñëó÷
ÐÅÇÓËÜÒÀÒÈ ÇÀÑÒÎÑÓÂÀÍÍß ÏÀÑÊ Â ÊÎÌÏËÅÊÑÍ²É Õ²Ì²ÎÒÅÐÀϲ¯ ÕÂÎÐÈÕ ÄÅÑÒÐÓÊÒÈÂÍÈÌ, ÐÀÍ²Ø ÍÅÅÔÅÊÒÈÂÍΠ˲ÊÎÂÀÍÈÌ, ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÌ ÒÓÁÅÐÊÓËÜÎÇÎÌ ËÅÃÅÍÜ

®

I. B. Byalik, L. M. Tsygankova, V. V. Davidenko, I. V. Slouch
RESULTS OF PASA APPLICATION IN COMPLEX CHEMOTHERAPY OF PATIENTS WITH DESTRUCTIVE, INEFFECTIVELY TREATED PREVIOUSLY, RESISTANT PULMONARY TUBERCULOSIS

 

Î. Ê. Àñìîëîâ, Î. Â. Ïàâëîâà, Ò. Ä. Êîòëÿðîâà
ÀÍÀË²Ç Ë²ÊÀÐÍßÍί ËÅÒÀËÜÍÎÑÒ² ÕÂÎÐÈÕ ÍÀ ÑÏÎËÓ×ÅÍÓ ÏÀÒÎËÎÃ²Þ Â²Ë/ÑÍ²Ä ÒÀ ÒÓÁÅÐÊÓËÜÎÇ Ó ÒÓÁÑÒÀÖ²ÎÍÀв

®

O. K. Asmolov, O. V. Pavlova, T. D. Kotlyarova
THE ANALYSIS OF MORTALITY AMONG PATIENTS WITH HIV/AIDS AND TUBERCULOSIS AT TUBERCULOSIS HOSPITAL

 

È. À. Ñèðåíêî, Ñ. À. Øìàòüêî
ÎÑÎÁÅÍÍÎÑÒÈ L-ÀÐÃÈÍÈÍÇÀÂÈÑÈÌÎÃÎ ÑÈÍÒÅÇÀ ÎÊÑÈÄÀ ÀÇÎÒÀ Ó ÄÅÒÅÉ È ÏÎÄÐÎÑÒÊÎÂ, ÁÎËÜÍÛÕ ÒÓÁÅÐÊÓ˨ÇÎÌ ÎÐÃÀÍΠÄÛÕÀÍÈß

®

I. A. Sirenko, S. A. Schmatko
PECULIARITIES OF L-ARGININE-DEPENDENT SYNTHESIS OF NITRIC OXIDE IN CHILDREN AND ADOLESCENTS WITH TUBERCULOSIS OF RESPIRATORY ORGANS

 

 

ÎÃËßÄÈ Ë²ÒÅÐÀÒÓÐÈ / LITERATURE REVIEW
 

Ë. Ì. Êóðèê
Ô²ÇÈÊÎ-ղ̲×Ͳ ÀÑÏÅÊÒÈ ÑÈÍÃËÅÒÍÎ-ÊÈÑÍÅÂί ÒÅÐÀϲ¯ Ó Ë²ÊÓÂÀÍͲ ÏÀÒÎËÎò×ÍÈÕ ÏÐÎÖÅѲÂ

®

L. M. Kurik
PHYSICAL-CHEMICAL ASPECTS OF SINGLET-OXYGEN THERAPY OF PATHOLOGICAL CONDITIONS

 

Ê˲Ͳ×Ͳ ÑÏÎÑÒÅÐÅÆÅÍÍß / CLINICAL OBSERVATIONS

 

Â. Â. Áóãåðóê, Þ. Â. ̳òàñîâ, Î. Ô. Êîñò³øèí, Ò. Ä. Íîñîâà
ËÅÃÅÍÅÂÈÉ ÀËÜÂÅÎËßÐÍÈÉ ÏÐÎÒůÍÎÇ-вÄʲÑÍÈÉ Ê˲Ͳ×ÍÈÉ ÂÈÏÀÄÎÊ

®

V. V. Bugeruk, Yu. V. Mitasov, A. F. Kostishin, T. D. Nosova
PULMONARY ALVEOLAR PROTEINOSIS-RARE CLINICAL CASE

 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

ÀÂÒÎÐÀÌ ÆÓÐÍÀËÜÍÈÕ ÏÓÁ˲ÊÀÖ²É
®

INSTRUCTIONS TO THE AUTHORS

Ïåðåõîä íà òèòóëüíóþ ñòðàíèöó

È

HomeÏîèñê Ïðî èíñòèòóòÍîâîñòè Íàøè èçäàíèÿ Îðèãèíàëüíûå ñòàòòüè Íîâîââåäåíèÿ
ÏàòåíòûÎò÷åòû î ÍÄÐ Ïîäãîòîâêà êàäðîâ Íàó÷íûå ôîðóìû 
Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâÈíôîðìàöèÿ äëÿ íàñåëåíèÿÌåäèöèíñêèå óñëóãè


<

© Îòäåë ÈÊÒ
ÍÈÔÏ

Îòïðàâèòü E-mail â Èíñòèòóò

www.ifp.kiev.ua